1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,033 | 0,037 | 20.03. |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Fr | Lifecare ASA: Financial calendar | - | Oslo Børs | ||
| Mo | Lifecare ASA: Disclosure of shareholding | 17 | Oslo Børs | ||
| 13.03. | Lifecare ASA: Final results following expiry of exercise period for Warrants Series 1 issued in connection with Rights Issue | 3 | Oslo Børs | ||
| 13.03. | Lifecare ASA: Mandatory notification of trade | 3 | Oslo Børs | ||
| 13.03. | Lifecare ASA: Last day of the Exercise Period for Warrants Series 1 issued in connection with the Rights Issue | 4 | Oslo Børs | ||
| LIFECARE ASA Aktie jetzt für 0€ handeln | |||||
| 12.03. | Lifecare ASA: European Commission recognises Lifecare innovations in implantable glucose monitoring | 10 | Oslo Børs | ||
| 11.03. | Correction: Lifecare ASA: Mandatory notification of trade | 1 | Oslo Børs | ||
| 06.03. | Lifecare ASA: Last day of trading in Warrants Series 1 issued in connection with the Rights Issue | 10 | Oslo Børs | ||
| 05.03. | Lifecare ASA: Mandatory notification of trade | - | Oslo Børs | ||
| 05.03. | Lifecare ASA: Lifecare confirms 12-week implant stability under real-life conditions materially reduces durability risk ahead of first-in-human study | 5 | Oslo Børs | ||
| 03.03. | LIFE: Lifecare ASA Q4 2025 results | 4 | Oslo Børs | ||
| 02.03. | Lifecare ASA: Commencement of the Exercise Period for Warrants Series 1 issued in connection with the Rights Issue | 1 | Oslo Børs | ||
| 27.02. | Lifecare ASA: Exercise price for Warrants Series 1 issued in connection with the Rights Issue | 1 | Oslo Børs | ||
| 26.02. | Lifecare ASA: Lifecare reaches regulatory milestone - veterinary product cleared for sales in Europe | 15 | Oslo Børs | ||
| 25.02. | Lifecare ASA appoints Petter Nielsen as Chief Financial Officer | 18 | Oslo Børs | ||
| 24.02. | Lifecare ASA: Invitation to Q4 2025 results presentation | - | Oslo Børs | ||
| 23.02. | Lifecare ASA: Lifecare signs EU Declaration of Conformity for implant electronics | 2 | Oslo Børs | ||
| 19.02. | Lifecare ASA: Lifecare receives notification of intended grant in European patent application and provides update on IP strategy | 2 | Oslo Børs | ||
| 17.02. | Lifecare ASA: Lifecare completes production-level compliance testing of implant electronics - moves to finalize CE claim | 1 | Oslo Børs | ||
| 11.02. | Lifecare ASA: Major shareholding notifications | - | Oslo Børs |
1 2 3 Weiter >>
57 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ROKU | 80,33 | -0,52 % | Roku's ad-free streaming service was already a great deal - now it's adding Disney movies | ||
| SERNOVA BIOTHERAPEUTICS | 0,098 | -0,51 % | Sernova Biotherapeutics Inc: Sernova says Swetlow fired over trip, improper payouts | ||
| BOSTON SCIENTIFIC | 60,60 | -1,62 % | Truist senkt Kursziel für Boston Scientific wegen Bewertung | ||
| PAUL HARTMANN | 215,00 | +0,47 % | PAUL HARTMANN schließt Geschäftsjahr 2025 mit Umsatz- und Ergebnissteigerung ab | Heidenheim (ots) - - Organisches Umsatzwachstum beträgt 2,2 %; Umsatzerlöse betragen 2.449,6 Mio. EUR - Bereinigtes EBITDA steigt um 15,5 Mio. EUR gegenüber Vorjahr auf 276,9 Mio. EUR - Transformationsprogramm... ► Artikel lesen | |
| SYSMEX | 7,700 | +1,32 % | Sysmex Corporation Bottom Line Drops In Nine Months | TOKYO (dpa-AFX) - Sysmex Corporation (SSMXY.PK) announced a profit for nine months that Dropped, from the same period last yearThe company's earnings came in at JPY33.694 billion, or JPY54.05... ► Artikel lesen | |
| ADDLIFE | 12,750 | -1,47 % | AddLife AB: AddLife acquires BioSpectrum Ltd | AddLife acquires BioSpectrum Ltd, a fast-growing distributor of surgical solutions in the fields of urology, gynaecology and general surgery in the UK. The company will be included within AddLife's... ► Artikel lesen | |
| EMBECTA | 7,800 | +1,30 % | Embecta Corp.: embecta Announces Definitive Agreement to Acquire Owen Mumford Holdings Limited | PARSIPPANY, N.J., March 19, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. ("Embecta") (Nasdaq: EMBC), a global leader in diabetes care technology, today announced that it has entered into a definitive agreement... ► Artikel lesen | |
| ENOVIS | 19,200 | +1,59 % | Enovis Corporation: Update: Enovis Announces Fourth Quarter and Full Year 2025 Results | Continued commercial momentum with full year 2025 sales growth of 7% on a reported basis and 6% organically Full year 2025 Reconstructive sales grew 10% Y/Y on a reported basis and 8% on an organic... ► Artikel lesen | |
| PULMONX | 1,180 | -7,09 % | Pulmonx Corporation: Pulmonx Reports Fourth Quarter and Full Year 2025 Financial Results | REDWOOD CITY, Calif., March 04, 2026 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) ("Pulmonx" or the "Company"), a global leader in minimally invasive treatments for lung disease, today reported... ► Artikel lesen | |
| KOOTH | 1,250 | 0,00 % | Kooth PLC - Notice of Full Year Results | ||
| PEIJIA MEDICAL | 0,590 | -4,06 % | PEIJIA-B (09996): VOLUNTARY ANNOUNCEMENT - DCWIRE MICRO GUIDEWIRE RECEIVES FDA 510(K) CLEARANCE | ||
| BACTIGUARD | 1,360 | +2,64 % | Bactiguard Holding AB: Bactiguard Holding AB's year-end report 2025 | A year of strategic execution concluded with a strong Q4
Fourth quarter 2025 (October - December)
Total revenue amounted to SEK 65.6 (68.3) million, a decrease of SEK 2.7 million corresponding to... ► Artikel lesen | |
| SI-BONE | 10,700 | -2,73 % | Smith & Nephew Plc: Smith+Nephew signs distribution agreement with SI-BONE | Trauma and Extremities partnership aligns disciplined approach to portfolio optimization and focuses on delivering long-term value for surgeons and patients Smith+Nephew (LSE:SN, NYSE:SNN), the global... ► Artikel lesen | |
| REVITALIST LIFESTYLE AND WELLNESS | 0,015 | -100,00 % | Revitalist Lifestyle and Wellness Ltd: Revitalist Lifestyle CEO Walker, CFO Murray resign | ||
| SCIBASE | 0,005 | 0,00 % | Scibase Holding AB: Interim report | January 1 - December 31, 2025
The fourth quarter in figures
Net sales were TSEK 12,475 (8,598), +45%, cleared for currency effects +57%.
The loss after tax was TSEK 25,300 (21,677).
The loss per... ► Artikel lesen |
LIFECARE ASA gehört der Branche Gesundheitswesen an. Der aktuelle Kurs liegt bei 0,033 Euro und damit 0,00 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu LIFECARE ASA finden Sie auf Wallstreet Online.